Výsledky vyhledávání - "Richard de Rooij"

Akademický článek

Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults

Autor: Isabel Leroux-Roels, Geert Leroux-Roels, Georgi Shukarev, Hanneke Schuitemaker, Conor Cahill, Richard de Rooij, Martin Struijs, Hester van Zeeburg, Jeanne-Marie Jacquet

Publikováno v: Human Vaccines & Immunotherapeutics, Vol 17, Iss 5, Pp 1366-1373 (2021)

This first-in-human study (NCT03032588), conducted in Belgium, evaluated a new inactivated poliovirus vaccines (IPV) candidate based on Sabin poliovirus strains grown on the high-yield PER.C6® cell line. Healthy adults (N = 32) were randomized (1:1)

Externí odkaz: https://doaj.org/article/8d9a181505c642feaf0a71a258804c4c

Zobrazit plný text záznamu

Akademický článek

Safety and tolerability of cell culture-derived and egg-derived trivalent influenza vaccines in 3 to

Autor: Javier Diez-Domingo, Maurizio de Martino, Jose Garcia-Sicilia Lopez, Gian Vincenzo Zuccotti, Giancarlo Icardi, Alberto Villani, David Moreno-Perez, María Méndez Hernández, Javier Álvarez Aldeán, Ahmed Abdul Mateen, Igwebuike Enweonye, Richard de Rooij, Richa Chandra

Publikováno v: International Journal of Infectious Diseases, Vol 49, Iss C, Pp 171-178 (2016)

Background: This descriptive, non-comparative, phase III study evaluated the safety and tolerability of cell culture-derived (TIVc) and egg-derived (TIV) seasonal influenza vaccines in children at risk of influenza-related complications. Methods: Fou

Externí odkaz: https://doaj.org/article/1512c1629fc44987930db8d3ae8774ca

Zobrazit plný text záznamu

Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults

Autor: Hester van Zeeburg, Conor Cahill, Jeanne-Marie Jacquet, Richard de Rooij, Martin Struijs, Isabel Leroux-Roels, Geert Leroux-Roels, Georgi Shukarev, Hanneke Schuitemaker

Publikováno v: Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
HUMAN VACCINES & IMMUNOTHERAPEUTICS

This first-in-human study (NCT03032588), conducted in Belgium, evaluated a new inactivated poliovirus vaccines (IPV) candidate based on Sabin poliovirus strains grown on the high-yield PER.C6 (R) cell line. Healthy adults (N = 32) were randomized (1:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93eb0628fbc5dacd2dab900dbc6f172c
https://doi.org/10.1080/21645515.2020.1812315

Zobrazit plný text záznamu

Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multicenter, observer-blind study

Autor: Shelly Senders, Peter Jaehnig, Richard de Rooij, Richa Chandra, Terry Nolan, Tawee Chotpitayasunondh, Simon Carson, Maria Rosario Capeding

Publikováno v: Vaccine. 34(2):230-236

BackgroundCell culture-derived inactivated influenza vaccines (TIVc) are necessary for scale and predictability of production to meet global demand. This study compared the safety and tolerability of TIVc with an egg-derived trivalent influenza vacci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd1059a5325f115e40ea0da99f9403f

Zobrazit plný text záznamu

Safety and tolerability of cell culture-derived and egg-derived trivalent influenza vaccines in 3 to < 18-year-old children and adolescents at risk of influenza-related complications

Autor: Gian Vincenzo Zuccotti, Alberto Villani, Richard de Rooij, María Méndez Hernández, Maurizio de Martino, Jose Garcia Sicilia Lopez, Giancarlo Icardi, Igwebuike Enweonye, Javier Díez-Domingo, Ahmed Abdul Mateen, David Moreno-Pérez, Javier Álvarez Aldeán, Richa Chandra

Publikováno v: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
International Journal of Infectious Diseases, Vol 49, Iss C, Pp 171-178 (2016)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98949d3edebdfd6622b611f8ce570fb8
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1708

Zobrazit plný text záznamu

A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

Autor: Geert Leroux-Roels, Frederick Wittke, Leah Martell, Richard de Rooij, Peter M Dull, Fien De Boever, Lisa Bedell, Cathy Maes, Karen Slobod, Julie Willekens

Publikováno v: Vaccine. 34(15)

Background Group B streptococcus (GBS) is a leading cause of sepsis and meningitis in early infancy. Substantial data demonstrate that women with higher levels of circulating antibody against the capsular polysaccharide (CPS) deliver infants at reduc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9260357e0aa0244c29960c02f87b407d
https://pubmed.ncbi.nlm.nih.gov/26928074

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání